$1.30
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqCM:BRTX
BioRestorative Therapies Annual Report
| Year | Year | 2023 | ||
|---|---|---|---|---|
| Rev. | Revenue |
|
$0.15M | |
| GM % | Gross Margin % |
|
100.00% | |
| OM | Operating Margin |
|
0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-3.42 |
| Div. | Dividends |
|
$0.00 | |
| PR % | Payout Ratio % |
|
0 | |
| Sha. | Shares |
|
4.71m | |
| OCF | Operating Cash Flow |
|
$-6.43M | |
| FCF | Free Cash Flow |
|
$-6.60M | |
| FCFS | Free Cash Flow Per Share |
|
$-1.56 |
